Onesource Specialty Pharma Limited
Authum Investment & Infrastructure reduced its stake in Onesource Specialty Pharma Limited from 5.16% to 4.96% by decreasing its shareholding from 5,909,646 to 5,681,844 shares. This involved selling 227,802 shares for ₹35.75 crore at ₹1571.30 apiece, crossing the 5% disclosure threshold.
A specialist pharmaceutical company engaged in the research, development, and manufacturing of biological drug products in injectable formats for therapeutic use. OneSource Specialty Pharma provides comprehensive contract development and manufacturing organization services spanning all phases of preclinical and clinical development, alongside commercial supply of biologics to domestic and international pharmaceutical clients and healthcare providers.
BSE-listed NBFC (market cap ~Rs 38,000 cr) controlled by Sanjay and Alpana Dangi, with around Rs 15,300 cr deployed across listed and unlisted Indian equities and credit. One of India's most aggressive listed proprietary investment vehicles, with concentrated multi-bagger positions and disclosed stakes in 10+ listed companies.
